Bridgewater Associates’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,730
Closed -$293K 814
2024
Q4
$293K Sell
5,730
-2,478
-30% -$122K ﹤0.01% 631
2024
Q3
$338K Sell
8,208
-1,205
-13% -$57.9K ﹤0.01% 726
2024
Q2
$453K Sell
9,413
-39,537
-81% -$1.75M ﹤0.01% 759
2024
Q1
$2.35M Sell
48,950
-6,960
-12% -$372K 0.01% 475
2023
Q4
$3.63M Sell
55,910
-5,109
-8% -$308K 0.02% 420
2023
Q3
$3.99M Buy
61,019
+8,530
+16% +$537K 0.02% 391
2023
Q2
$3.05M Buy
52,489
+370
+0.7% +$23.3K 0.02% 400
2023
Q1
$3.22M Buy
52,119
+893
+2% +$53.6K 0.02% 380
2022
Q4
$3.26M Sell
51,226
-16,732
-25% -$1.21M 0.02% 446
2022
Q3
$4.94M Buy
67,958
+819
+1% +$61K 0.03% 381
2022
Q2
$4.57M Buy
67,139
+11,974
+22% +$861K 0.02% 508
2022
Q1
$5M Buy
55,165
+18,304
+50% +$1.5M 0.02% 476
2021
Q4
$3.36M Sell
36,861
-9,400
-20% -$806K 0.02% 382
2021
Q3
$3.75M Sell
46,261
-3,688
-7% -$310K 0.02% 335
2021
Q2
$4.66M Buy
+49,949
New +$4.84M 0.03% 343

Other funds holding NARI

Bridgewater Associates's NARI Position: Q1 2025 in Review

Bridgewater Associates sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 5,730 shares — an estimated $293K sold.

Bridgewater Associates first reported a position in NARI in Q2 2021 and held it in 15 quarters. The position peaked at $5M in Q1 2022. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Bridgewater Associates reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Bridgewater Associates sold 5,730 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $293K.
  • Bridgewater Associates first reported a position in Inari Medical, Inc. Common Stock in Q2 2021 and held it in 15 quarters.
  • Bridgewater Associates's Inari Medical, Inc. Common Stock position peaked at $5M in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Bridgewater Associates's 13F filing for Q1 2025, filed 14 May 2025.